mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
Scott Dehm, PhD
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
Peter Buch, MD, FACG, AGAF, FACP
Vivek Kaul, MD
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC): From Diagnosis to Treatment
Efrat Dotan, MD
Shubham Pant, MD, MBBS
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Charles Turck, PharmD, BCPS, BCCCP
Paolo Tarantino, MD
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Sairah Ahmed, MD
Caron A. Jacobson, MD
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Jacob Sands, MD
Julia Rotow, MD
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
Laura Alder, MD
Immunotherapy for TNBC in the Perioperative Setting: Clinical Evidence and Considerations
Peter Schmid, FRCP, MD, PhD
Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence
Sara Lonardi, MD
Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC
First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study
Innovations in Oncology Learning Center From Guidelines to Practice: Gastrointestinal Cancers
Aparna R. Parikh, MD
Alan Venook, MD
Innovations in Oncology Learning Center: From Guidelines to Practice—Breast Cancer
William J. Gradishar, MD
Erica L. Mayer, MD, MPH
Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion
The Evolving Treatment Landscape for MBC: Emerging Therapies
The Role of HER2-Directed Therapy for Second-Line Treatment of HER2+ Metastatic Breast Cancer
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.